Sympagesic (500,0 mg + 4,0 mg)/ml Roztwór do wstrzykiwań Polen - Polnisch - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

sympagesic (500,0 mg + 4,0 mg)/ml roztwór do wstrzykiwań

dechra regulatory b.v. - metamizolum natricum monohydricum + hyoscini butylbromidum - roztwór do wstrzykiwań - (500,0 mg + 4,0 mg)/ml - bydło; koń; pies; świnia

Orfadin Europäische Union - Polnisch - EMA (European Medicines Agency)

orfadin

swedish orphan biovitrum international ab - nitisinon - tyrosinemias - inne przewodu pokarmowego i przemianę materii narzędzia, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

Scorpion 325 SC Polen - Polnisch - Ministerstwo Rolnictwa i Rozwoju Wsi

scorpion 325 sc

syngenta agro gmbh regional headquarters technologiepark, d-63477 maintal, republika federalna niemiec - azoksystrobina; difenokonazol - azoksystrobina - 200 g, difenokonazol - 125 g - fungicyd

Ortiva Top 325 SC Polen - Polnisch - Ministerstwo Rolnictwa i Rozwoju Wsi

ortiva top 325 sc

syngenta polska sp. z o.o. ul. szamocka, 01-748 warszawa - azoksystrobina - 200 g, difenokonazol - 125 g - fungicyd

Tarantula 325 SC Polen - Polnisch - Ministerstwo Rolnictwa i Rozwoju Wsi

tarantula 325 sc

agrosimex sp. z o.o. 05-620 goliany - azoksystrobina - 200 g, difenokonazol - 125 g - fungicyd

Revus 250 SC Polen - Polnisch - Ministerstwo Rolnictwa i Rozwoju Wsi

revus 250 sc

syngenta polska sp. z o.o. ul. szamocka, 01-748 warszawa - mandipropamid - mandipropamid - 250 g w 1 litrze środka - fungicyd

Mandius 250 SC Polen - Polnisch - Ministerstwo Rolnictwa i Rozwoju Wsi

mandius 250 sc

agrosimex sp. z o.o. 05-620 goliany - mandipropamid - 250 g - fungicyd

Blincyto Europäische Union - Polnisch - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - prekursor komórkowy limfoblastyczny białaczka-chłoniak - Środki przeciwnowotworowe - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.